Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 30, 2011

View Archived Issues

QLT reports promising phase II data on L-PPDS in glaucoma

Bristol-Myers Squibb small-molecule MAP kinase p38 alpha inhibitor shows promise to treat arthritis

Pfizer describes discovery and investigation of AMPA receptor modulator now in phase I

Additional analyses of AVERROES study presented

Daewoong Pharmaceutical discloses new antifungal agents

Novel plant extracts prepared by German researchers

Hanmi Holdings presents new epidermal growth factor receptor inhibitors

Nanoemulsion-based RSV vaccine achieves durable viral clearance in vivo

GSK synthesizes novel interferon inducers

N30 Pharmaceuticals patents new alcohol dehydrogenase class-3 inhibitors

U.S. universities claim novel serotonin 5-HT2C receptor agonists

Boehringer Ingelheim begins new afatinib trials in breast cancer

Stellar Biotechnologies receives National Science Foundation grant

Talon Therapeutics and FDA reach agreement on HALLMARQ trial

Novartis seeks Japanese approval of tobramycin

Pharming returns certain Ruconest marketing rights to Swedish Orphan Biovitrum

Immuron to begin clinical testing of influenza product

Ipsen and Inspiration Biopharmaceuticals sign European partnership agreement in hemophilia

FDA grants fast track status to letermovir

Brain-penetrant inhibitor of kynurenine aminotransferase II described by Pfizer

Adimab announces new collaborations

FDA clears new anti-CCP assay for diagnosis of rheumatoid arthritis

NuPathe receives FDA complete response letter regarding Zelrix NDA

FDA accepts Relistor sNDA for filing

Cyclacel announces initiation of phase II trial of sapacitabine capsules

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...